Detalles de la búsqueda
1.
Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
Int J Neurosci
; 129(2): 119-128, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29792372
2.
Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections.
J Exp Med
; 198(4): 521-31, 2003 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-12925671
3.
TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages: interferon-beta-dependent signaling in TLR4-mediated responses.
J Endotoxin Res
; 9(3): 169-75, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12831458
4.
Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages.
J Immunol
; 174(7): 4252-61, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15778388
5.
Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
J Immunol
; 169(9): 5209-16, 2002 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12391239
6.
CD55/decay accelerating factor is part of the lipopolysaccharide-induced receptor complex.
Eur J Immunol
; 33(5): 1399-408, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12731067
Resultados
1 -
6
de 6
1
Próxima >
>>